Douwe Postmus
Douwe Postmus
Researcher, University of Groningen, University Medical Center Groningen, The Netherlands
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure
P van der Meer, D Postmus, P Ponikowski, JG Cleland, CM O'Connor, ...
Journal of the American College of Cardiology 61 (19), 1973-1981, 2013
A stochastic multicriteria model for evidence‐based decision making in drug benefit‐risk analysis
T Tervonen, G Van Valkenhoef, E Buskens, HL Hillege, D Postmus
Statistics in Medicine 30 (12), 1419-1428, 2011
Hit-and-run enables efficient weight generation for simulation-based multiple criteria decision analysis
T Tervonen, G van Valkenhoef, N Baştürk, D Postmus
European Journal of Operational Research 224 (3), 552-559, 2013
Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer
J Widder, D Postmus, JF Ubbels, EM Wiegman, JA Langendijk
International Journal of Radiation Oncology* Biology* Physics 81 (4), e291-e297, 2011
Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
A Abbasi, E Corpeleijn, E Meijer, D Postmus, RT Gansevoort, ROB Gans, ...
Diabetologia 55 (7), 1963-1970, 2012
Multicriteria benefit–risk assessment using network meta-analysis
G van Valkenhoef, T Tervonen, J Zhao, B de Brock, HL Hillege, ...
Journal of clinical epidemiology 65 (4), 394-403, 2012
Prognostic value of serial ST2 measurements in patients with acute heart failure
LC van Vark, I Lesman-Leegte, SJ Baart, D Postmus, YM Pinto, JG Orsel, ...
Journal of the American College of Cardiology 70 (19), 2378-2388, 2017
Renal function trajectories and clinical outcomes in acute heart failure
MM Givertz, D Postmus, HL Hillege, GA Mansoor, BM Massie, BA Davison, ...
Circulation: Heart Failure 7 (1), 59-67, 2014
Long-term compliance with nonpharmacologic treatment of patients with heart failure
MMW Nieuwenhuis, T Jaarsma, DJ van Veldhuisen, D Postmus, ...
The American journal of cardiology 110 (3), 392-397, 2012
The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure
D Postmus, DJ van Veldhuisen, T Jaarsma, ML Luttik, J Lassus, ...
European journal of heart failure 14 (2), 168-175, 2012
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome
A Abbasi, E Corpeleijn, D Postmus, RT Gansevoort, PE De Jong, ...
The Journal of Clinical Endocrinology & Metabolism 95 (9), E26-E31, 2010
Incorporating patient preferences into drug development and regulatory decision making: results from a quantitative pilot study with cancer patients, carers, and regulators
D Postmus, M Mavris, HL Hillege, T Salmonson, B Ryll, A Plate, I Moulon, ...
Clinical Pharmacology & Therapeutics 99 (5), 548-554, 2016
Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention
T Tervonen, H Naci, G van Valkenhoef, AE Ades, A Angelis, HL Hillege, ...
Medical Decision Making 35 (7), 859-871, 2015
Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study
J Biegus, HL Hillege, D Postmus, MAE Valente, DM Bloomfield, ...
European Journal of Heart Failure 18 (7), 830-839, 2016
Quantitative release planning in extreme programming
G van Valkenhoef, T Tervonen, B de Brock, D Postmus
Information and software technology 53 (11), 1227-1235, 2011
A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure
D Postmus, AAA Pari, T Jaarsma, ML Luttik, DJ van Veldhuisen, ...
American heart journal 162 (6), 1096-1104, 2011
An economic model to compare the profitability of pay-per-use and fixed-fee licensing
D Postmus, J Wijngaard, H Wortmann
Information and Software Technology 51 (3), 581-588, 2009
Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure
N van Boven, I Kardys, LC van Vark, KM Akkerhuis, MWJ de Ronde, ...
European journal of heart failure 20 (1), 89-96, 2018
Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All‐Cause Mortality
A Abbasi, E Corpeleijn, D Postmus, RT Gansevoort, PE de Jong, ...
Journal of the American Heart Association 1 (5), e002956, 2012
Structured frameworks to increase the transparency of the assessment of benefits and risks of medicines: current status and possible future directions
F Pignatti, D Ashby, EP Brass, HG Eichler, P Frey, HL Hillege, A Hori, ...
Clinical Pharmacology & Therapeutics 98 (5), 522-533, 2015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20